CAS NO:1138245-21-2  Mirogabalin besylate
CAS NO:1138245-21-2  Mirogabalin besylate
CAS NO:1138245-21-2  Mirogabalin besylate
CAS NO:1138245-21-2  Mirogabalin besylate
CAS NO:1138245-21-2  Mirogabalin besylate
CAS NO:1138245-21-2  Mirogabalin besylate
+
  • CAS NO:1138245-21-2  Mirogabalin besylate
  • CAS NO:1138245-21-2  Mirogabalin besylate
  • CAS NO:1138245-21-2  Mirogabalin besylate
  • CAS NO:1138245-21-2  Mirogabalin besylate
  • CAS NO:1138245-21-2  Mirogabalin besylate
  • CAS NO:1138245-21-2  Mirogabalin besylate

CAS NO:1138245-21-2 Mirogabalin besylate

CAS NO:1138245-21-2 NAME:Mirogabalin besylate MF:C18H25NO5S MW:367.46 Purity:98% Appearance:white powder COA:Provide Sample:Negotiable

Categories:

Life Science Chemicals

Pharmaceutical Intermediates

Product introduction

PRODUCT NAME  Mirogabalin besylate
CAS NO 1138245-21-2
Other name  2-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid besylate
STORAGE 2-8°C
DELIVERY 2-3DAYS
PACKAGE According client's request

Description of CAS NO:1138245-21-2  Mirogabalin besylate

Mirogabalin besylate CAS NO:1138245-21-2  is a drug that is used to treat neuropathic pain, postherpetic neuralgia, and other disorders. Mirogabalin besylate is an analog of gabapentin with increased solubility in water and a decreased solubility in organic solvents. Mirogabalin besylate has been shown to be safe and have a good efficacy profile in clinical development. It has also been shown to be effective in the treatment of depression.


Mirogabalin besylate (DS-5565)CAS NO:1138245-21-2  is a novel potent, selective ligand of the α2δ subunit of voltage-gated calcium channels . It is a member of the gabapentinoid drug class, which includes gabapentin and pregabalin . Mirogabalin was developed by Daiichi Sankyo and was first approved in Japan for the treatment of peripheral neuropathic pain (PNP), including diabetic PNP and postherpetic neuralgia .
 

 

 


Applications of CAS NO:1138245-21-2  Mirogabalin besylate

1.Treatment of Peripheral Neuropathic Pain

2.Analgesic Effects in Fibromyalgia Models

3.Treatment of Postherpetic Neuralgia 

4.Anxiolytic Effects in Neuropathic Pain Model 

Future Directions:

Mirogabalin besylate shows promise as a novel, safe gabapentinoid anticonvulsant with a greater therapeutic effect for neuropathic pain in the dorsal root ganglion and lower adverse drug reactions in the cerebellum . Further studies are needed to explore the role of mirogabalin in cancer pain, postoperative pain, and neuropathic pain due to various other etiologies .

Key words:

Related Products

Related Products

Inquiry

SUBMIT